Procurou por: CID-2858522

66 resultados encontrados

Filtrar resultados Ordenar por

Sort Results

Visualização em Lista Easy View (new)

Compare(0) Limpar

Classifique os resultados da pesquisa

CID-2858522 ≥98%

Fornecedor: Cayman Chemical

Descrição: CID-2858522 ≥98%

6-Hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic cid ≥98.0% (por GC, análise de titulação)

Fornecedor: TCI

Descrição: 6-Hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic cid ≥98.0% (by GC, titration analysis)

6-Hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic cid ≥96.5% (by titrimetric analysis)

Código de Artigo: (ENZOALX270267M100)

Fornecedor: ENZO LIFE SCIENCES

Descrição: Cell permeable derivative of vitamin E. Antioxidant. Inhibits peroxynitrite mediated tyrosine nitration and mitochondrial proton permeability. Prevents lipid peroxidation, cytotoxicity and apoptosis induced by cytochrome P450 2E1 in HEP G2 cells.

UOM: 1 * 100 mg

Novo produto Promoção

N/A cada

6-Hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic cid 97%

Fornecedor: Thermo Fisher Scientific

Descrição: CAS No.: 53188-07-1

MSDS Certificados

Anti-CID Rabbit Polyclonal Antibody

Código de Artigo: (ABCAAB10887-100)

Fornecedor: Abcam

Descrição: Anti-CID Rabbit Polyclonal Antibody

UOM: 1 * 100 µG

Promoção

N/A cada

Anti-ACOX1 Rabbit Polyclonal Antibody

Código de Artigo: (BOSSBS-5021R)

Fornecedor: Bioss

Descrição: Defects in ACOX1 are the cause of adrenoleukodystrophy pseudoneonatal (Pseudo-NALD); also known as peroxisomal acyl-CoA oxidase deficiency. Pseudo-NALD is a peroxisomal single-enzyme disorder. Clinical features include mental retardation, leukodystrophy, seizures, mild hepatomegaly, hearing deficit. Pseudo-NALD is characterized by increased plasma levels of very-long chain fatty cids, due to decreased or absent peroxisome acyl-CoA oxidase activity. Peroxisomes are intact and functioning.

UOM: 1 * 100 µl

Promoção